top of page

Dr. Marco Gottardis describes his background in biopharma and why he’s excited to join LIfT as a Non-Executive Director

In this interview, Dr. Marco Gottardis outlines his background in cell therapy and biopharma, including his most recent role as VP of Oncology and Innovation at Janssen. He describes how he met Alex Blyth, LIfT’s CEO, and why he is excited to showcase LIfT’s unique platform, with its potential to synergise with existing IO therapies and overcome the hurdles of cellular therapies in solid tumours.



Stay up-to-date with our progress and latest news
bottom of page